Tarsus Pharmaceuticals, Inc.
TARS
Rang în acțiuni
#4678
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Preț acțiune
$68.99
Capitalizare de piață
$3.23B
Schimbare (1 zi)
1.34%
Schimbare (1 an)
-5.41%
Țară
US
Tranzacționează Tarsus Pharmaceuticals, Inc. (TARS)
Categorie
Healthcare
EPS pentru Tarsus Pharmaceuticals, Inc. (TARS)
EPS la data de June 2026 TTM: $-1.09
Conform celor mai recente rapoarte financiare și prețului acțiunilor Tarsus Pharmaceuticals, Inc., EPS-ul actual al companiei (TTM) este $-1.09. La sfârșitul anului 2023, compania avea un EPS de $-4.62 o creștere față de EPS-ului din 2022, care a fost de $-2.52.
Istoricul EPS pentru Tarsus Pharmaceuticals, Inc. din 2018 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-1.09 | -64.50% |
| 2024 | $-3.07 | -33.55% |
| 2023 | $-4.62 | 83.33% |
| 2022 | $-2.52 | 276.12% |
| 2021 | $-0.67 | -49.24% |
| 2020 | $-1.32 | 450.00% |
| 2019 | $-0.24 | -22.58% |
| 2018 | $-0.31 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $17.32 | -1,688.99% |
US
|
|
| $-7.98 | 632.11% |
US
|
|
| $-5.29 | 385.32% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,644.95% |
NL
|
